Login / Signup

Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients.

Loredana PettineMarta BortolottiBruno FattizzoMatteo C Da ViàDario ConsonniAlessandra PompaNiccolò BolliLuca Baldini
Published in: Hematological oncology (2022)
Keyphrases
  • sars cov
  • end stage renal disease
  • multiple myeloma
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis